As of 2025-10-15, the Relative Valuation of SQZ Biotechnologies Co (SQZ) is (36.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on Relative Valuation is -8493.2%.
The range of the Relative Valuation is (29.32) - (42.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 15.7x | 13.6x |
| Forward P/E multiples | 10.8x - 17.2x | 13.5x |
| Fair Price | (29.32) - (42.20) | (36.51) |
| Upside | -6839.4% - -9800.2% | -8493.2% |
| Date | P/E |